NCT01046630View on ClinicalTrials.gov

Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Depression
Interventions
DRUG

AZD6765

single infusion

DRUG

Ketamine

single infusion

DRUG

Placebo

single infusion

Trial Locations (2)

Unknown

Research Site, Manchester

Research Site, Oxford

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

University of Manchester

OTHER

collaborator

University of Oxford

OTHER

lead

AstraZeneca

INDUSTRY